Fred Alger Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Fred Alger Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-8,455	Closed	-$181K	–	580
2022 Q4	$181K	Buy	+8,455	New	+$180K	﹤0.01%	431
2022 Q2	–	Sell	-345,881	Closed	-$5.82M	–	562
2022 Q1	$5.82M	Sell	345,881 -110,035	-24%	-$1.63M	0.02%	259
2021 Q4	$7.62M	Sell	455,916 -69,528	-13%	-$1.14M	0.02%	260
2021 Q3	$8.53M	Buy	+525,444	New	+$5.72M	0.02%	252

Other funds holding ISEE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fred Alger Management's ISEE Position: Q1 2023 in Review

Fred Alger Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2023, closing a stake of 8,455 shares — an estimated $181K sold.

Fred Alger Management first reported a position in ISEE in Q3 2021 and held it in 4 quarters. The position peaked at $8.53M in Q3 2021. 223 funds tracked by Wall St. Rank hold ISEE as of Q1 2023.

Fred Alger Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Fred Alger Management sold 8,455 IVERIC bio, Inc. Common Stock shares in Q1 2023, an estimated $181K.
Fred Alger Management first reported a position in IVERIC bio, Inc. Common Stock in Q3 2021 and held it in 4 quarters.
Fred Alger Management's IVERIC bio, Inc. Common Stock position peaked at $8.53M in Q3 2021.
223 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2023.

Based on Fred Alger Management's 13F filing for Q1 2023, filed 15 May 2023.